Childhood cancers: open trials in Norway

42 open trials have a site in Norway. Registry data; only the trial team decides who can take part.

NCT04924075
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC
Oslo Universitetssykehus Radiumhospitalet (Site 2400), Oslo
Registry updated 2026-11-03
NCT03435796
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Trial Treatment · Phase 2/3 · Celgene
Oslo University Hospital HF, Oslo
Registry updated 2026-11-02
NCT07476729
International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
Trial Treatment · Phase 3 · Charite University, Berlin, Germany
Helse Bergen HF, Bergen · Oslo University Hospital HF, Oslo · Universitetssykehuset Nord-Norge HF, Tromsoe · St. Olavs hospital HF, Trondheim
Registry updated 2026-10-26
NCT05476939
Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0
Trial Treatment · Phase 3 · Gustave Roussy, Cancer Campus, Grand Paris
Helse Bergen HF, Bergen · Oslo Universitetssykehus HF, Oslo · St. Olavs hospital HF, Trondheim
Registry updated 2026-10-21
NCT07297914
Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL
Trial Treatment · Phase 2/3 · Bambino Gesù Hospital and Research Institute
University Hospital, Oslo
Registry updated 2026-10-20
NCT05327894
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Trial Treatment · Phase 3 · Princess Maxima Center for Pediatric Oncology
Helse Bergen HF, Bergen · Oslo University Hospital HF, Oslo · University Hospital Of North Norway HF, Tromsoe · St. Olavs hospital HF, Trondheim
Registry updated 2026-10-19
NCT01356290
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
Trial Treatment · Phase 2 · Medical University of Vienna
Helse Bergen HF, Bergen · Oslo University Hospital HF, Oslo · St. Olavs hospital HF, Trondheim
Registry updated 2026-10-13
NCT06697301
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Trial Treatment · Phase 2/3 · Eikon Therapeutics
Nordlandssykehuset HF, Bodo · Vestre Viken HF, Drammen · Oslo University Hospital HF, Oslo
Registry updated 2026-10-06
NCT06079671
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
Trial Treatment · Phase 3 · AstraZeneca
Oslo University Hospital HF, Oslo · Universitetssykehuset Nord-Norge HF, Tromsoe · St. Olavs hospital HF, Trondheim
Registry updated 2026-09-30
NCT05748171
A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
Trial Treatment · Phase 2 · Pfizer
Oslo University Hospital HF, Oslo
Registry updated 2026-09-24
2023-504999-25-00
CHIP-AML22 Master protocol: Protocol for the treatment of children and adolescents with Acute Myeloid Leukemia (AML)
Trial Treatment · Phase 3 · Prinses Maxima Centrum voor Kinderoncologie B.V.
Helse Bergen HF, Bergen · Oslo University Hospital HF, Oslo · Universitetssykehuset Nord-Norge HF, Tromsoe · St. Olavs hospital HF, Trondheim
Registry updated 2026-09-23
2022-501456-28-00
An international trial for children with atypical teratoid/rhabdoid tumours (ATRT)
Trial Treatment · Phase 3 · GPOH gGmbH
Helse Bergen HF, Bergen · Oslo University Hospital HF, Oslo · St. Olavs hospital HF, Trondheim
Registry updated 2026-09-14
2024-510578-25-00
SIOP-HRMB: An international prospective trial on clinically high-risk medulloblastoma (HR-MB) in patients older than 3 years.
Trial Treatment · Phase 3 · The University Of Birmingham
Haukeland Universitetssykehus, Bergen · Oslo University Hospital HF, Oslo · St. Olavs hospital HF, Trondheim
Registry updated 2026-09-04
NCT01949129
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Trial Treatment · Phase 2/3 · St. Anna Kinderkrebsforschung
Oslo University Hospital HF, Oslo
Registry updated 2026-09-04
NCT03911128
A Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
Research · Mats Heyman
Haukeland University Hospital, Dept of Paediatrics, Bergen · Haukeland University Hospital, Dept of Haematology, Bergen · Oslo University Hospital, Dept of Haematology, Oslo · Oslo University Hospital, Dept of paediatric haemato- and oncology, Oslo · Stavanger University Hospital, Dept of Haematology, Stavanger · University Hospital of North Norway, Dept of Paediatrics, Tromsø · University Hospital North Norway, Dept of Haematology, Tromsø · St. Olavs University Hospital, Dept of Haematology, Trondheim · St. Olavs University Hospital, Dept of Paediatrics, Trondheim
Registry updated 2026-08-13
NCT02300766
Cerebellar Mutism Syndrome Study
Research · Copenhagen University Hospital, Rigshospitalet
Haukeland University Hospital, Bergen · Oslo University Hospital, Oslo · University Hospital of North Norway, Tromsø · St. Olav's Hospital, Trondheim
Registry updated 2026-08-12
NCT04307576
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
Trial Treatment · Phase 3 · Mats Heyman
Helse Bergen HF, Bergen · Oslo University Hospital HF, Oslo · Helse Stavanger HF, Stavanger · Universitetssykehuset Nord-Norge HF, Tromsoe · St. Olavs hospital HF, Trondheim
Registry updated 2026-08-12
2025-522453-20-00
Individualized Intrathecal Chemotherapy Based on Measurement of Brain Fluid Clearance in Pediatric Patients
Trial Treatment · Phase 2 · Oslo University Hospital HF
Oslo University Hospital HF, Oslo
Registry updated 2026-08-04
NCT05503797
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Trial Treatment · Phase 2 · Fore Biotherapeutics
Helse Bergen HF, Bergen · Oslo University Hospital HF, Oslo
Registry updated 2026-07-27
NCT02265770
SIOP Ependymoma II: An International Clinical Program for the diagnosis and treatment of children, adolescents and young adults with ependymoma
Trial Treatment · Phase 2/3 · Centre Leon Berard
Helse Bergen HF, Bergen · Oslo University Hospital HF, Oslo · St. Olavs hospital HF, Trondheim
Registry updated 2026-06-10
2025-520982-39-00
Study on chemotherapy and experimental drugs in patients with Philadelphia Chromosome positive and ABL-class Philadelphia Chromosome-Like B-cell Acute Lymphoblastic Leukemia
Trial Treatment · Phase 3 · Universita Degli Studi Di Milano Bicocca
Oslo University Hospital HF, Oslo · The University Hospital of North Norway (UNN), Tromsø · St. Olavs hospital HF, Trondheim
Registry updated 2026-05-08
2023-504880-18-00
A phase 1B of crizotinib either in combination or as single agent in pediatric patients with ALK, ROS1 or MET positive malignancies
Trial Treatment · Phase 1/2 · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
St. Olavs hospital HF, Trondheim
Registry updated 2026-05-07
NCT04043494
International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
Trial Treatment · Phase 3 · University Hospital Muenster
Helse Bergen HF, Bergen · Oslo University Hospital HF, Oslo · Universitetssykehuset Nord-Norge HF, Tromsoe · St. Olavs hospital HF, Trondheim
Registry updated 2026-05-06
NCT03590171
International Study for Treatment of High Risk Childhood Relapsed ALL 2010
Trial Treatment · Phase 2 · Charite University, Berlin, Germany
Oslo University Hospital, Oslo
Registry updated 2026-03-17
NCT07334301
A Multi-Arm, Platform Trial For Relapsed Neuroblastoma
Trial Treatment · Phase 1/2 · University of Birmingham
Oslo University Hospital HF, Oslo
Registry updated 2026-01-12

All Childhood cancers trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error